Literature DB >> 8051280

Performance of three commercially available monoclonal reagents for confirmation of Chlamydia pneumoniae in cell culture.

G S Montalban1, P M Roblin, M R Hammerschlag.   

Abstract

We evaluated the performance of three commercially available monoclonal antibodies for confirmation of the presence of Chlamydia pneumoniae in cell culture by examining their abilities to stain inclusions of eight strains of C. pneumoniae. The antibodies tested were two unconjugated C. pneumoniae-specific monoclonal reagents and one conjugated genus-specific reagent. All three produced similar intensities of staining of C. pneumoniae, with some strain-to-strain variation. Methanol appeared to be a better choice of fixative than acetone, which greatly reduced the intensity of fluorescence with one of the species-specific antibodies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051280      PMCID: PMC263716          DOI: 10.1128/jcm.32.5.1406-1407.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.

Authors:  P M Roblin; W Dumornay; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

2.  Nucleotide sequence and taxonomic value of the major outer membrane protein gene of Chlamydia pneumoniae IOL-207.

Authors:  M W Carter; S A al-Mahdawi; I G Giles; J D Treharne; M E Ward; I N Clark
Journal:  J Gen Microbiol       Date:  1991-03

3.  Identification of a new group of Chlamydia psittaci strains called TWAR.

Authors:  C C Kuo; H H Chen; S P Wang; J T Grayston
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

4.  Use of HL cells for improved isolation and passage of Chlamydia pneumoniae.

Authors:  L D Cles; W E Stamm
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

5.  Chlamydial infection. Results of micro-immunofluorescence tests for the detection of type-specific antibody in certain chlamydial infections.

Authors:  R S Dwyer; J D Treharne; B R Jones; J Herring
Journal:  Br J Vener Dis       Date:  1972-12

6.  Infection with Chlamydia pneumoniae in Brooklyn.

Authors:  K Chirgwin; P M Roblin; M Gelling; M R Hammerschlag; J Schachter
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

Review 7.  A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.

Authors:  J T Grayston; L A Campbell; C C Kuo; C H Mordhorst; P Saikku; D H Thom; S P Wang
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

8.  Chlamydia pneumoniae elementary body antigenic reactivity with fluorescent antibody is destroyed by methanol.

Authors:  S P Wang; J T Grayston
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

9.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

  9 in total
  3 in total

1.  Laboratory diagnosis of Chlamydia pneumoniae infections.

Authors:  R W Peeling
Journal:  Can J Infect Dis       Date:  1995-07

2.  Failure to detect Chlamydia trachomatis in cell culture by using a monoclonal antibody directed against the major outer membrane protein.

Authors:  J Boman; C Gaydos; P Juto; G Wadell; T C Quinn
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

Review 3.  Chlamydiae as pathogens: new species and new issues.

Authors:  R W Peeling; R C Brunham
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.